Abstract
Purpose
Management of the unexplained AFP elevation after transplantation. F18 FDG PET/CT may not be helpful to detect post-transplant brain metastasis of hepatocellular carcinoma (HCC).
Case Report
A-61-year old male patient with HBV related HCC have undergone living donor liver transplantation after successfully downstaging. AFP level started to increase on Post-transplant one year and there was no detectable metastases on PET/CT, abdominal thorax tomography. Patient admitted to hospital with confusion and seizure on post-transplant 16th month and diagnosed brain metastasis by brain tomography. Surgical resection was performed but the patientd died on post-transplant 20th month.
Conclusion
In the unexplained elevation of AFP after transplantation, it is beneficial to keep brain metastases in mind and perform cranial scanning with conventional imaging methods (CT, MRI) rather than FDG PET.
Similar content being viewed by others
References
de’Angelis N, Landi F, Carra MC, Azoulay D. Managements of recurrent hepatocellular carcinoma after liver transplantation: a systematic review. World J Gastroenterol. 2015;21;21(39):11185–98. https://doi.org/10.3748/wjg.v21.i39.11185. (PMID: 26494973).
Filgueira NA. Hepatocellular carcinoma recurrence after liver transplantation: risk factors, screening and clinical presentation. World J Hepatol. 2019;27;11(3):261–72. https://doi.org/10.4254/wjh.v11.i3.261. (PMID: 30967904).
Seinfeld J, Wagner AS, Kleinschmidt-DeMasters BK. Brain metastases from hepatocellular carcinoma in US patients. J Neurooncol. 2006;76(1):93–8. https://doi.org/10.1007/s11060-005-4175-3 (PMID: 16402279).
Au KP, Chok KSH. Multidisciplinary approach for post-liver transplant recurrence of hepatocellular carcinoma: a proposed management algorithm. World J Gastroenterol 2018;7;24(45):5081–94. https://doi.org/10.3748/wjg.v24.i45.5081. (PMID: 30568386).
Hsieh MJ, Lu CH, Tsai NW, Lui CC, Chuang YC, Huang CR, Chen SF, Chang CC, Chang HW, Chang WN. Prediction, clinical characteristics and prognosis of intracerebral hemorrhage in hepatocellular carcinoma patients with intracerebral metastasis. J Clin Neurosci. 2009;16(3):394–8. https://doi.org/10.1016/j.jocn.2008.05.010 (Epub 2009 Jan 14 PMID: 19147364).
Kim YK, Lee KW, Cho SY, Han SS, Kim SH, Kim SK, Park SJ. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients. Liver Transpl. 2010;16(6):767–72. https://doi.org/10.1002/lt.22069 (PMID: 20517911).
Liao X, Wei J, Li Y, Zhong J, Liu Z, Liao S, Li Q, Wei C. 18F-FDG PET with or without CT in the diagnosis of extrahepatic metastases or local residual/recurrent hepatocellular carcinoma. Medicine (Baltimore). 2018;97(34):e11970. https://doi.org/10.1097/MD.0000000000011970 (PMID: 30142825).
Asman Y, Evenson AR, Even-Sapir E, Shibolet O. [18F]fludeoxyglucose positron emission tomography and computed tomography as a prognostic tool before liver transplantation, resection, and loco-ablative therapies for hepatocellular carcinoma. Liver Transpl. 2015;21(5):572–80. https://doi.org/10.1002/lt.24083 (Epub 2015 Apr 1 PMID: 25644857).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sahin, E., Ince, V., Sahin, T.T. et al. Undetectable Brain Metastasis of Hepatocellular Carcinoma by PET-CT After Liver Transplantation: a Case Report. J Gastrointest Canc 54, 270–274 (2023). https://doi.org/10.1007/s12029-021-00767-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-021-00767-y